Fluoroquinolones: Difference between revisions

No edit summary
No edit summary
Line 5: Line 5:
* [[PID]]
* [[PID]]
* [[Traveler's Diarrhea]]
* [[Traveler's Diarrhea]]
==Adverse Effects==
*Black box warning from US FDA
#Tendon Rupture & Tendinitis <ref>Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2</ref>
#Peripheral Neuropathy<ref>Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy [http://www.fda.gov/downloads/Drugs/DrugSafety/UCM365078.pdf PDF]</ref>


{{Template:Clinically Utilized Antibiotics}}
{{Template:Clinically Utilized Antibiotics}}
Line 12: Line 19:


==Source==
==Source==
Goodman & Gilman's Pharmacology
*Goodman & Gilman's Pharmacology
 
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals]
<references/>
[[Category:ID]]
[[Category:ID]]
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 22:35, 17 May 2014

Indications

Adverse Effects

  • Black box warning from US FDA
  1. Tendon Rupture & Tendinitis [1]
  2. Peripheral Neuropathy[2]


See Also

Source

  1. Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2
  2. Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy PDF